BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26678657)

  • 1. Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report.
    Neychev V; Sadowski SM; Zhu J; Allgaeuer M; Kilian K; Meltzer P; Kebebew E
    J Clin Endocrinol Metab; 2016 Feb; 101(2):353-8. PubMed ID: 26678657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
    Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline PTEN mutations in Cowden syndrome-like families.
    Marsh DJ; Dahia PL; Caron S; Kum JB; Frayling IM; Tomlinson IP; Hughes KS; Eeles RA; Hodgson SV; Murday VA; Houlston R; Eng C
    J Med Genet; 1998 Nov; 35(11):881-5. PubMed ID: 9832031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cowden syndrome: report of two cases with immunohistochemical analysis for PTEN expression.
    Zabetian S; Mehregan D
    Am J Dermatopathol; 2012 Aug; 34(6):632-4. PubMed ID: 22481496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Germline
    Lopez C; Abuel-Haija M; Pena L; Coppola D
    Cancer Genomics Proteomics; 2018; 15(2):115-120. PubMed ID: 29496690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
    Ngeow J; Eng C
    Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer.
    Tate G; Suzuki T; Endo Y; Mitsuya T
    Cancer Genet Cytogenet; 2008 Jul; 184(1):67-71. PubMed ID: 18558293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells.
    Yu W; Ni Y; Saji M; Ringel MD; Jaini R; Eng C
    Hum Mol Genet; 2017 Apr; 26(7):1365-1375. PubMed ID: 28164237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.
    Teresi RE; Zbuk KM; Pezzolesi MG; Waite KA; Eng C
    Am J Hum Genet; 2007 Oct; 81(4):756-67. PubMed ID: 17847000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cowden syndrome.
    Gustafson S; Zbuk KM; Scacheri C; Eng C
    Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer.
    Agrawal S; Eng C
    Hum Mol Genet; 2006 Mar; 15(5):777-87. PubMed ID: 16436456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of PTEN gene mutations in a Turkish patient with Cowden syndrome.
    Soysal Y; Tate G; Polat C; Polat N; Aktepe F; Sivaci Y; Imirzalioglu N
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):547-51. PubMed ID: 19604110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.
    Ngeow J; He X; Mester JL; Lei J; Romigh T; Orloff MS; Milas M; Eng C
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2320-7. PubMed ID: 23066114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian Clear Cell Carcinoma in Cowden Syndrome.
    Yauy K; Imbert-Bouteille M; Bubien V; Lindet-Bourgeois C; Rathat G; Perrochia H; MacGrogan G; Longy M; Bessis D; Tinat J; Baert-Desurmont S; Blanluet M; Perre PV; Baudry K; Pujol P; Corsini C
    J Natl Compr Canc Netw; 2019 Jan; 17(1):7-11. PubMed ID: 30659124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.
    Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes.
    Ni Y; Zbuk KM; Sadler T; Patocs A; Lobo G; Edelman E; Platzer P; Orloff MS; Waite KA; Eng C
    Am J Hum Genet; 2008 Aug; 83(2):261-8. PubMed ID: 18678321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel PTEN mutation in Cowden syndrome: case report with late diagnosis and non-malignant course.
    Martínez-Doménech A; García-Legaz Martínez M; Magdaleno-Tapial J; Pérez-Pastor G; Rodríguez-López R; Pérez-Ferriols A
    Dermatol Online J; 2019 May; 25(5):. PubMed ID: 31220904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heterozygous germline mutation of the PTEN/MMAC1 gene in a patient with Cowden disease.
    Iida S; Nakamura Y; Fujii H; Kimura M; Moriwaki K
    Int J Mol Med; 1998 Mar; 1(3):565-8. PubMed ID: 9852263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
    Pilarski R; Burt R; Kohlman W; Pho L; Shannon KM; Swisher E
    J Natl Cancer Inst; 2013 Nov; 105(21):1607-16. PubMed ID: 24136893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.